title: Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
authors.affiliation: Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Siena
authors.forename: S
authors.initials: S
authors.lastname: Villa
authors.forename: G
authors.initials: G
authors.lastname: Bonadonna
authors.forename: M
authors.initials: M
authors.lastname: Bregni
authors.forename: A M
authors.initials: AM
authors.lastname: Gianni
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology* / Q000379:methods; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D037102:Lectins / Q000627:therapeutic use*; D008212:Lymphocyte Depletion; D037121:Plant Lectins; D012276:Ricin / Q000627:therapeutic use*; D030262:Soybean Proteins; D013025:Glycine max; D013601:T-Lymphocytes / Q000276:immunology*; D010835:Phytohemagglutinins
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D037102:Lectins; D037121:Plant Lectins; D012276:Ricin; D030262:Soybean Proteins; C028824:soybean lectin; D010835:Phytohemagglutinins